Peri-operative treatment with flurbiprofen axetil modulates the naturally circulating dendritic cells subsets from patients with esophageal carcinoma undergoing thoracic surgery

王迪,柴小青,疏树华,张晓琳,魏昕,谢言虎
DOI: https://doi.org/10.3969/j.issn.1009-6469.2015.12.043
2015-01-01
Abstract:Objective To investigate whether flurbiprofen axetil ( FA) modulates the naturally circulating dendritic cells ( DCs) sub-setsinpatientswithesophagealcarcinomaundergoingthoracicsurgery.Methods 20healthysubjectswereenraued40patientsun-dergoing esophageal radical resection for carcinoma were randomly assigned into two groups, group C ( control group, n=20 ) and group F (intervention group, n=20).FA (2 mg· kg-1) was administered i.v.30 min before skin incision and at the end of surgery in group F while placebo was adopted in group C.Both groups received postoperative ( post-OP) patient-controlled intravenous anal-gesia ( PCIA) using sufentanil.The percentages of plasmacytoid ( p) DCs and myeloid( m) DCs subtypes among peripheral blood mono-nuclear cells ( PBMCs) were measured by flow cytometry ( FCM) .Furthermore, visual analogue scale ( VAS) scores, sufentanil con-sumption during post-OP 48 h were recorded.Results FCM results showed that percentages of pDCs and mDCs in patients preoper-atively ( pre-OP) were significantly lower compared to those in healthy donors.In comparison with group C, treatment with FA signif-icantly up-regulated the depressed percentages of pDCs and mDCs in patients after surgery ( post-OP 24 h) .It also provided a simi-lar analgesic effect on patients according to VAS score, and brought a significantly less sufentanil consumption during post-OP 48 h. Conclusion Peri-operative treatment with FA alleviated the surgery-induced suppressed circulating pDCs, and mDCs percentages in patients with esophageal carcinoma undergoing esophageal radical resection.
What problem does this paper attempt to address?